Juvéderm Volbella

Juvéderm Volbella with Lidocaine is a hyaluronic acid injectable by Allergan Aesthetics, developed for the correction of fine lines, moderate skin depressions and lip enhancement. It is suitable for authorised medical practitioners for improving lip volume and contour and correcting appropriate facial depressions and volume loss. The product contains cross-linked hyaluronic acid at 15 mg/mL and 3 mg/mL of lidocaine hydrochloride and is intended for professional use. Each box contains two 1 mL pre-filled syringes, four single-use 32G 1/2" needles and traceability labels.

• Injectable implant for fine lines and medium-sized skin depressions due to conditions such as premature ageing
• Also indicated for enhancement and pouting of the lips, correcting asymmetry, contour deformities and volume loss
• Hyaluronic acid gel 15 mg with lidocaine hydrochloride 3 mg per mL, in phosphate buffer at pH 7.2
• Injected into the superficial or mid-dermis or the lip mucosa, and in the submuscular or pre-periosteal plane for the tear trough
• Cross-linked hyaluronic acid of non-animal origin, sterile and pyrogen-free
• Contains lidocaine, so no separate anaesthetic is needed at the injection site
• Each box holds two 1 mL syringes with four single-use 32G 1/2 inch needles and traceability labels
• The composition is compatible with fields used for magnetic resonance imaging

適応と専門的な使用

主な適応

• Fine lines and medium-sized skin depressions due to conditions such as premature ageing
• Infraorbital skin depressions, also known as the tear trough area
• Enhancement and pouting of the lips, correcting asymmetry, contour deformities and volume loss

専門的な使用

Juvéderm Volbella is an injectable medical device to be administered only by an authorised medical practitioner in a controlled clinical setting, and is not supplied for retail sale or self-administration. It is intended for intradermal injection for fine lines and moderate skin depressions, injection into the mucous membrane for the lips, and submuscular or pre-periosteal injection for the tear trough and infraorbital area. It must not be injected into the eyelids, and must not be injected into blood vessels, since intravascular injection may lead to embolisation, occlusion of the vessels, ischaemia or infarction; it must not be overcorrected. In patients with a pre-existing tendency for infraorbital oedema there is no clinical data for treatment in that region, and such patients must be warned of the potential increased risk of prolonged oedema. Volbella is not interchangeable with other Juvéderm references, which differ in hyaluronic acid concentration and intended depth.

施術部位

• Lips
• Perioral area
• Undereye and infraorbital hollow area

対象となる患者

For adult patients (18 years and over) assessed as suitable by the treating practitioner, typically those seeking subtle definition rather than pronounced volume. Selection, injected volume, plane and technique follow the practitioner's clinical assessment. Contraindications, warnings and limitations for use must be reviewed before treatment, including known hypersensitivity to any component. Treatment of the infraorbital area in particular requires assessment of skin thickness, fluid retention and vascular risk in that region, and is undertaken only by practitioners trained in that technique.

作用の仕組み： Juvéderm Volbella ​

Allparaで注文する理由

Allparaは、正規品で検証済みの JUVÉDERM 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問